These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26572534)

  • 1. Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.
    Taler M; Vered I; Globus R; Shbiro L; Weizman A; Weller A; Gil-Ad I
    J Mol Neurosci; 2016 Jan; 58(1):66-73. PubMed ID: 26572534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
    Gil-Ad I; Portnoy M; Tarasenko I; Bidder M; Kramer M; Taler M; Weizman A
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):425-36. PubMed ID: 24389121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Deng C
    PLoS One; 2012; 7(3):e33548. PubMed ID: 22438946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.
    Lian J; Huang XF; Pai N; Deng C
    Psychoneuroendocrinology; 2014 Oct; 48():77-86. PubMed ID: 24992721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.
    Davoodi N; Kalinichev M; Korneev SA; Clifton PG
    Psychopharmacology (Berl); 2009 May; 203(4):693-702. PubMed ID: 19052729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity.
    He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF
    Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of thermogenesis in antipsychotic drug-induced weight gain.
    Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
    Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of hypothalamic AMPK on serine(485/491) related to sustained weight loss by alpha-lipoic acid in mice treated with olanzapine.
    Kim H; Park M; Lee SK; Jeong J; Namkoong K; Cho HS; Park JY; Lee BI; Kim E
    Psychopharmacology (Berl); 2014 Oct; 231(20):4059-69. PubMed ID: 24733236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats.
    Sejima E; Yamauchi A; Nishioku T; Koga M; Nakagama K; Dohgu S; Futagami K; Kataoka Y
    Cell Mol Neurobiol; 2011 Oct; 31(7):985-9. PubMed ID: 21681559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
    Han M; Deng C; Burne TH; Newell KA; Huang XF
    Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
    Beebe KL; Block T; Debattista C; Blasey C; Belanoff JK
    Behav Brain Res; 2006 Aug; 171(2):225-9. PubMed ID: 16782211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short and long-term treatment with antipsychotics on orexigenic/anorexigenic neuropeptides expression in the rat hypothalamus.
    Rojczyk E; Pałasz A; Wiaderkiewicz R
    Neuropeptides; 2015 Jun; 51():31-42. PubMed ID: 25888224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of hypothalamic modulation in olanzapine treated male rats.
    Sezlev-Bilecen D; Ak M; Yanik T
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():103-7. PubMed ID: 27353111
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.
    Choi S; DiSilvio B; Unangst J; Fernstrom JD
    Life Sci; 2007 Sep; 81(12):1024-30. PubMed ID: 17822717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways.
    Lian J; De Santis M; He M; Deng C
    Pharmacol Res; 2015; 95-96():20-6. PubMed ID: 25782398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats.
    Nakhate KT; Subhedar NK; Kokare DM
    Brain Res; 2018 Sep; 1695():45-52. PubMed ID: 29775565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways.
    Liu X; Lian J; Hu CH; Deng C
    Pharmacol Res; 2015 Oct; 100():36-46. PubMed ID: 26218603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance.
    Guesdon B; Denis RG; Richard D
    Behav Brain Res; 2010 Feb; 207(1):14-20. PubMed ID: 19788900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat.
    Davey KJ; Cotter PD; O'Sullivan O; Crispie F; Dinan TG; Cryan JF; O'Mahony SM
    Transl Psychiatry; 2013 Oct; 3(10):e309. PubMed ID: 24084940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.